Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fibroblast growth factor for regeneration of tympanic membrane perforations has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibroblast Growth Factor (Fibroblast Growth Factor)

Snippet

Sponsor: D. Bradley Welling, MD, PhD | Conditions: Tympanic Membrane Perforation | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11